查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
呼吸道疾病疫苗市場規模、佔有率和趨勢分析報告：按類型、年齡層、感染疾病、配銷通路、地區、細分市場預測，2023-2030年
市場調查報告書
商品編碼
1321337

呼吸道疾病疫苗市場規模、佔有率和趨勢分析報告：按類型、年齡層、感染疾病、配銷通路、地區、細分市場預測，2023-2030年

Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report By Type (Viral, Bacterial, Combination), By Age Group, By Infection (COVID-19, Influenza), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

呼吸道疾病疫苗市場成長和趨勢

Grand View Research, Inc.最新報告顯示，預計2023年至2030年全球呼吸道疫苗市場規模將以1.21%的複合年複合成長率成長，2030年將達到703億美元。

呼吸道疾病疫苗市場的成長歸因於人們對疫苗接種重要性的認知提高、呼吸道感染疾病發病率上升以及疫苗技術的進步。此外，COVID-19 大流行極大地凸顯了呼吸道疫苗的重要性，進一步加速了市場的發展。

呼吸道疫苗，特別是針對流感和肺炎的疫苗，對於減輕醫療保健系統的負擔並最大程度地降低與 COVID-19 合併感染的風險至關重要。為了防止病毒傳播並防止疫情爆發，醫療保健提供者正在重點關注疫苗接種，以保護個人免受流感等呼吸道病原體的侵害。近年來，由於疫苗技術的進步，特別是針對SARS-CoV-2的疫苗的開發，呼吸道疫苗市場大幅成長。 COVID-19疫苗的成功開發、批准和部署證明了科學界快速應對呼吸道威脅的能力，並為呼吸道疫苗研發的未來進展鋪平了道路。

此外，政府在國家和全球層面的支持和監督，以監測流感疫苗的供應、流行和實施，是推動市場成長的關鍵因素。此外，主要企業增加對新型疫苗市場引進的投資也有助於市場的成長。例如，輝瑞公司最近透露，計劃於 2022 年 9 月開始其基於 mRNA 的流感疫苗的 3 期臨床試驗。該試驗將涉及美國25,000 名 18 歲及以上的人。

此外，參與各種呼吸道疾病疫苗開發和配製的主要公司正在注重建立夥伴關係和協作，以開發新疫苗並保持市場競爭力。此外，人們對植物來源藥物提供的自然療法的興趣日益濃厚，預計將在預測期內提振市場。此外，許多公司正在進行地域擴張和分銷，以滿足對藥品不斷成長的需求。例如，2023年5月，輝瑞公司的RSV疫苗ABRYSVO獲得FDA批准，用於預防60歲及以上人群由RSV引起的下呼吸道疾病。

呼吸道疾病疫苗市場報告亮點

  • 按類型分類，由於病毒性呼吸道疾病的患病率不斷上升，病毒疫苗細分市場在 2022 年佔據了最大的銷售佔有率。
  • 按年齡層分類，由於兒科人群疫苗配方的增加，預計兒科市場在預測期內將呈現最快的成長率。
  • 就感染疾病而言，由於開發疫苗以阻止 COVID-19 病毒傳播的需求不斷成長，2022 年，COVID-19 細分市場佔據主導地位。
  • 市場上的主要企業不斷關注地域擴張和產品發布，以保持自己的地位。
  • 由於主要參與者的存在、醫療基礎設施的不斷完善、慢性病病例的增加以及充足的疫苗接種服務的可用性，北美在 2022 年佔據了最大的收入佔有率。

目錄

第1章 呼吸道疾病疫苗市場：調查方法和範圍

  • 市場區隔和範圍
    • 區域範圍
    • 估計/預測時間表
    • 目的
  • 調查方法
  • 資訊採購
    • 購買數據庫
    • GVR內部數據庫
    • 次要資訊
    • 初步調查
  • 資訊或資料分析
    • 資料分析模型
  • 市場形成和檢驗
  • 型號詳情
    • 產品流向分析
  • 二手資訊清單
  • 簡稱列表

第2章 呼吸道疾病疫苗市場：執行摘要

  • 市場簡介
  • 類型和年齡層簡介
  • 傳播管道和感染簡介
  • 競爭形勢概覽

第3章 呼吸道疾病疫苗市場：行業展望

  • 市場譜系預測
    • 母公司市場譜系預測
    • 相關/附帶市場預測
  • 採用和成長預測圖
  • 市場動態
    • 市場促進因素
    • 市場抑制因素分析
  • 按因素（政治/法律、經濟/技術）進行 SWOT 分析
  • 行業分析-波特
  • 贖回和法規場景
  • 主要交易和戰略聯盟
    • 新產品發布
    • 獲得
    • 擴張
    • 合夥
    • 行銷和推廣

第4章 呼吸系統疾病疫苗市場：競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
    • 安索夫矩陣
  • 企業分類
    • 創新者
  • 供應商形勢
    • 主要經銷商及管道合作夥伴名單
    • 主要客戶
    • 2022年主要企業市場佔有率分析
  • 上市公司
    • 競爭儀表板分析
  • 民營企業
    • 主要新興企業名單
  • 區域網路圖

第5章 呼吸道疾病疫苗市場：類型業務分析

  • 定義和範圍
  • 2022 年和 2030 年類型市場佔有率分析
  • 2018-2030 年全球呼吸道疾病疫苗市場（按類型）
  • 呼吸道疾病疫苗市場：類型變異分析
  • 病毒疫苗
  • 細菌疫苗
  • 聯合疫苗

第6章 呼吸系統疾病疫苗市場：按年齡層進行的業務分析

  • 定義和範圍
  • 2022 年和 2030 年年齡段市場佔有率分析
  • 全球呼吸道疾病疫苗市場（按年齡層），2018-2030
  • 呼吸道疾病疫苗市場：年齡層變化分析
  • 孩子
  • 成人

第7章 呼吸道疾病疫苗市場：感染疾病業務分析

  • 定義和範圍
  • 2022 年和 2030 年感染疾病市場佔有率分析
  • 全球呼吸道疾病疫苗市場（按感染疾病），2018-2030
  • 呼吸道疾病疫苗市場：感染波動分析
  • COVID-19
  • 流感
  • RS病毒
  • 肺炎
  • 其他

第8章 呼吸道疾病疫苗市場：配銷通路業務分析

  • 定義和範圍
  • 2022 年和 2030 年配銷通路市場佔有率分析
  • 2018-2030年全球呼吸道疾病疫苗市場（按配銷通路）
  • 呼吸道疾病疫苗市場：配銷通路波動分析
  • 醫院和零售藥房
    • 2018-2030 年醫院和零售藥房市場估計和預測
  • 政府供應商
  • 其他

第9章 呼吸系統疾病疫苗市場：區域業務分析

  • 定義和範圍
  • 2022 年和 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 區域市場簡介
  • 按因素（政治/法律、經濟/技術）進行 SWOT 分析
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 2022年至2030年市場規模、預測、趨勢分析
  • 北美
    • 2018年至2030年北美呼吸道疾病疫苗市場估計和預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲呼吸道疾病疫苗市場
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 2018-2030年亞太呼吸系統疾病疫苗市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 鯛魚
    • 澳大利亞
  • 拉丁美洲
    • 拉丁美洲呼吸道疾病疫苗市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東和非洲呼吸道疫苗市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 呼吸疫苗市場：公司概況

  • 企業分類
  • 戰略規劃
    • 新產品發布
    • 合夥
    • 獲得
    • 合作
    • 資金籌措
  • 2022年主要企業市場佔有率分析
  • 公司簡介
    • Gsk Plc.
    • Johnson & Johnson Services, Inc.
    • Pfizer Inc.
    • Sanofi
    • Serum Institute Of India Pvt. Ltd.
    • Sinovac
    • Bavarian Nordic
    • Merck & Co., Inc.
    • Astrazeneca
    • Emergent
    • Novavax
    • Inovio Pharmaceuticals
    • Moderna Inc.
Product Code: GVR-4-68040-093-9

Respiratory Disease Vaccine Market Growth & Trends

The global respiratory disease vaccine market size is expected to reach USD 70.30 billion by 2030, expanding at a CAGR of 1.21% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the respiratory disease vaccine market is attributable to increasing awareness associated with the importance of vaccination, the rising incidence of respiratory infections, and advancements in vaccine technology. Moreover, the COVID-19 pandemic has brought significant traction to the importance of respiratory vaccines which has further accelerated the market.

Respiratory vaccines, particularly those targeting influenza and pneumonia, are vital in reducing the burden on healthcare systems and minimizing the risk of co-infections with COVID-19. In order to prevent the spread of the virus and prevent the occurrence of outbreaks healthcare providers have been focusing on vaccination to protect individuals against respiratory pathogens like influenza. In recent years, the respiratory vaccine market has witnessed substantial growth attributed to advancements in vaccine technology, specifically in the development of vaccines targeting SARS-CoV-2. The successful development, approval, and deployment of COVID-19 vaccines have demonstrated the capacity of the scientific community to respond rapidly to respiratory threats and have paved the way for future advancements in respiratory vaccine research and development.

Moreover, government backing and surveillance at both national and global levels to monitor the availability, dissemination, and implementation of influenza vaccines is a crucial factor driving the growth of the market. Additionally, increased investments by prominent key players with a major focus on the introduction of novel vaccines into the market have contributed to the growth of the market. For instance, Pfizer recently disclosed their plans to commence Phase 3 clinical trials for their mRNA-based influenza vaccine in September 2022. This trial will involve a cohort of 25,000 individuals aged 18 and above from the U.S.

Furthermore, key players involved in developing and formulating various respiratory disease vaccines are focusing on collaborations and partnerships to develop novel vaccines and to maintain their competitive position in the market. In addition, increasing interest in plant-based medicines owing to natural remedies offered by them is expected to boost the market over the forecast period. Moreover, a number of players are involved in geographic expansion and distribution to meet the rising demand for medicinal products. For instance, in May 2023, Pfizer Inc. received FDA approval for ABRYSVO, a RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in the elderly population above the age of 60 years.

Respiratory Disease Vaccine Market Report Highlights

  • Based on type, the viral vaccine segment held the largest revenue share in 2022 owing to the increasing prevalence of viral respiratory conditions
  • Based on age group, the pediatric segment is expected to show the fastest growth rate over the forecast period owing to the rising formulation of vaccines for the pediatric population
  • On the basis of infection, the COVID-19 segment dominated in 2022 due to the growing need for the development of a vaccine to stop the spread of the COVID-19 virus
  • Key players operating in the market are constantly focusing on geographical expansion and product launches to maintain their presence
  • North America held the largest revenue share in 2022 which can be attributed to the presence of key players, rising healthcare infrastructure, growing cases of chronic disorders, and availability of proper vaccination service

Table of Contents

Chapter 1 Respiratory Disease Vaccine Market: Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Type Segment
      • 1.1.1.2 Age Group Segment
      • 1.1.1.3 Distribution Channel Segment
      • 1.1.1.4 Infection Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List Of Secondary Sources
  • 1.11 List Of Abbreviations

Chapter 2 Respiratory Disease Vaccine Market: Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Type And Age Group Snapshot
  • 2.3 Distribution Channel And Infection Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Respiratory Disease Vaccine Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Increasing Prevalence Of Respiratory Diseases
      • 3.3.1.2 Growing Awareness And Focus On Prevention
      • 3.3.1.3 Increasing Government Initiatives And Immunization Programs
      • 3.3.1.4 Growing Geriatric Population
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Complex And Time-Consuming Regulatory Approval Process
      • 3.3.2.2 High Price Associated With Vaccines
  • 3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Respiratory Disease Vaccine Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2022
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 Respiratory Disease Vaccine Market: Type Business Analysis

  • 5.1 Definition And Scope
  • 5.2 Type Market Share Analysis, 2022 & 2030
  • 5.3 Global Respiratory Disease Vaccine Market, By Type, 2018 To 2030
  • 5.4 Respiratory Disease Vaccine Market: Type Movement Analysis
  • 5.5 Viral Vaccine
    • 5.5.1 Viral Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Bacterial Vaccine
    • 5.6.1 Bacterial Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Combination Vaccine
    • 5.7.1 Combination Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Respiratory Disease Vaccine Market: Age Group Business Analysis

  • 6.1 Definition And Scope
  • 6.2 Age Group Market Share Analysis, 2022 & 2030
  • 6.3 Global Respiratory Disease Vaccine Market, By Age Group, 2018 To 2030
  • 6.4 Respiratory Disease Vaccine Market: Age Group Movement Analysis
  • 6.5 Pediatric
    • 6.5.1 Pediatric Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6 Adult
    • 6.6.1 Adult Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Respiratory Disease Vaccine Market: Infection Business Analysis

  • 7.1 Definition And Scope
  • 7.2 Infection Market Share Analysis, 2022 & 2030
  • 7.3 Global Respiratory Disease Vaccine Market, By Infection, 2018 To 2030
  • 7.4 Respiratory Disease Vaccine Market: Infection Movement Analysis
  • 7.5 Covid-19
    • 7.5.1 Covid-19 Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 Influenza
    • 7.6.1 Influenza Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.7 Respiratory Syncytial Virus (Rsv)
    • 7.7.1 Respiratory Syncytial Virus (Rsv) Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.8 Pneumonia
    • 7.8.1 Pneumonia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.9 Others
    • 7.9.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Respiratory Disease Vaccine Market: Distribution Channel Business Analysis

  • 8.1 Definition And Scope
  • 8.2 Distribution Channel Market Share Analysis, 2022 & 2030
  • 8.3 Global Respiratory Disease Vaccine Market, By Distribution Channel, 2018 To 2030
  • 8.4 Respiratory Disease Vaccine Market: Distribution Channel Movement Analysis
  • 8.5 Hospital & Retail Pharmacies
    • 8.5.1 Hospital & Retail Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Government Suppliers
    • 8.6.1 Government Suppliers Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.7 Others
    • 8.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Respiratory Disease Vaccine Market: Regional Business Analysis

  • 9.1 Definition & Scope
  • 9.2 Regional Market Share Analysis, 2022 & 2030
  • 9.3 Regional Market Dashboard
  • 9.4 Regional Market Snapshot
  • 9.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 9.5.1 North America
    • 9.5.2 Europe
    • 9.5.3 Asia Pacific
    • 9.5.4 Latin America
    • 9.5.5 MEA
  • 9.6 Market Size, & Forecasts, Trend Analysis, 2022 To 2030
  • 9.7 North America
    • 9.7.1 North America Respiratory Disease Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 9.7.2 U.S.
      • 9.7.2.1 U.S. Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.7.2.2 Key Country Dynamics
      • 9.7.2.3 Regulatory Framework
      • 9.7.2.4 Competitive Scenario
    • 9.7.3 Canada
      • 9.7.3.1 Canada Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.7.3.2 Key Country Dynamics
      • 9.7.3.3 Regulatory Framework
      • 9.7.3.4 Competitive Scenario
  • 9.8 Europe
    • 9.8.1 Europe Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
    • 9.8.2 Uk
      • 9.8.2.1 Uk Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.2.2 Key Country Dynamics
      • 9.8.2.3 Regulatory Framework
      • 9.8.2.4 Competitive Scenario
    • 9.8.3 Germany
      • 9.8.3.1 Germany Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.3.2 Key Country Dynamics
      • 9.8.3.3 Regulatory Framework
      • 9.8.3.4 Competitive Scenario
    • 9.8.4 Spain
      • 9.8.4.1 Spain Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.4.2 Key Country Dynamics
      • 9.8.4.3 Regulatory Framework
      • 9.8.4.4 Competitive Scenario
    • 9.8.5 France
      • 9.8.5.1 France Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.5.2 Key Country Dynamics
      • 9.8.5.3 Regulatory Framework
      • 9.8.5.4 Competitive Scenario
    • 9.8.6 Italy
      • 9.8.6.1 Italy Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.6.2 Key Country Dynamics
      • 9.8.6.3 Regulatory Framework
      • 9.8.6.4 Competitive Scenario
    • 9.8.7 Norway
      • 9.8.7.1 Norway Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.7.2 Key Country Dynamics
      • 9.8.7.3 Regulatory Framework
      • 9.8.7.4 Competitive Scenario
    • 9.8.8 Denmark
      • 9.8.8.1 Denmark Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.8.2 Key Country Dynamics
      • 9.8.8.3 Regulatory Framework
      • 9.8.8.4 Competitive Scenario
    • 9.8.9 Sweden
      • 9.8.9.1 Sweden Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.9.2 Key Country Dynamics
      • 9.8.9.3 Regulatory Framework
      • 9.8.9.4 Competitive Scenario
  • 9.9 Asia Pacific
    • 9.9.1 Asia Pacific Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
    • 9.9.2 Japan
      • 9.9.2.1 Japan Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.2.2 Key Country Dynamics
      • 9.9.2.3 Regulatory Framework
      • 9.9.2.4 Competitive Scenario
    • 9.9.3 China
      • 9.9.3.1 China Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.3.2 Key Country Dynamics
      • 9.9.3.3 Regulatory Framework
      • 9.9.3.4 Competitive Scenario
    • 9.9.4 India
      • 9.9.4.1 India Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.4.2 Key Country Dynamics
      • 9.9.4.3 Regulatory Framework
      • 9.9.4.4 Competitive Scenario
    • 9.9.5 South Korea
      • 9.9.5.1 South Korea Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.5.2 Key Country Dynamics
      • 9.9.5.3 Regulatory Framework
      • 9.9.5.4 Competitive Scenario
    • 9.9.6 Thailand
      • 9.9.6.1 Thailand Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.6.2 Key Country Dynamics
      • 9.9.6.3 Regulatory Framework
      • 9.9.6.4 Competitive Scenario
    • 9.9.7 Australia
      • 9.9.7.1 Australia Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.7.2 Key Country Dynamics
      • 9.9.7.3 Regulatory Framework
      • 9.9.7.4 Competitive Scenario
  • 9.10 Latin America
    • 9.10.1 Latin America Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
    • 9.10.2 Brazil
      • 9.10.2.1 Brazil Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.10.2.2 Key Country Dynamics
      • 9.10.2.3 Regulatory Framework
      • 9.10.2.4 Competitive Scenario
    • 9.10.3 Mexico
      • 9.10.3.1 Mexico Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.10.3.2 Key Country Dynamics
      • 9.10.3.3 Regulatory Framework
      • 9.10.3.4 Competitive Scenario
    • 9.10.4 Argentina
      • 9.10.4.1 Argentina Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.10.4.2 Key Country Dynamics
      • 9.10.4.3 Regulatory Framework
      • 9.10.4.4 Competitive Scenario
  • 9.11 MEA
    • 9.11.1 MEA Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
    • 9.11.2 South Africa
      • 9.11.2.1 South Africa Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.11.2.2 Key Country Dynamics
      • 9.11.2.3 Regulatory Framework
      • 9.11.2.4 Competitive Scenario
    • 9.11.3 Saudi Arabia
      • 9.11.3.1 Saudi Arabia Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.11.3.2 Key Country Dynamics
      • 9.11.3.3 Regulatory Framework
      • 9.11.3.4 Competitive Scenario
    • 9.11.4 UAE
      • 9.11.4.1 UAE Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.11.4.2 Key Country Dynamics
      • 9.11.4.3 Regulatory Framework
      • 9.11.4.4 Competitive Scenario
    • 9.11.5 Kuwait
      • 9.11.5.1 Kuwait Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.11.5.2 Key Country Dynamics
      • 9.11.5.3 Regulatory Framework
      • 9.11.5.4 Competitive Scenario

Chapter 10 Respiratory Disease Vaccine Market: Company Profiling

  • 10.1 Company Categorization
  • 10.2 Strategy Mapping
    • 10.2.1 New Product Launch
    • 10.2.2 Partnerships
    • 10.2.3 Acquisition
    • 10.2.4 Collaboration
    • 10.2.5 Funding
  • 10.3 Key Company Market Share Analysis, 2022
  • 10.4 Company Profiles
    • 10.4.1 Gsk Plc.
      • 10.4.1.1 Company Overview
      • 10.4.1.2 Financial Performance
      • 10.4.1.3 Product Benchmarking
      • 10.4.1.4 Strategic Initiatives
    • 10.4.2 Johnson & Johnson Services, Inc.
      • 10.4.2.1 Company Overview
      • 10.4.2.2 Financial Performance
      • 10.4.2.3 Product Benchmarking
      • 10.4.2.4 Strategic Initiatives
    • 10.4.3 Pfizer Inc.
      • 10.4.3.1 Company Overview
      • 10.4.3.2 Financial Performance
      • 10.4.3.3 Product Benchmarking
      • 10.4.3.4 Strategic Initiatives
    • 10.4.4 Sanofi
      • 10.4.4.1 Company Overview
      • 10.4.4.2 Financial Performance
      • 10.4.4.3 Product Benchmarking
      • 10.4.4.4 Strategic Initiatives
    • 10.4.5 Serum Institute Of India Pvt. Ltd.
      • 10.4.5.1 Company Overview
      • 10.4.5.2 Product Benchmarking
      • 10.4.5.3 Strategic Initiatives
    • 10.4.6 Sinovac
      • 10.4.6.1 Company Overview
      • 10.4.6.2 Product Benchmarking
      • 10.4.6.3 Strategic Initiatives
    • 10.4.7 Bavarian Nordic
      • 10.4.7.1 Company Overview
      • 10.4.7.2 Financial Performance
      • 10.4.7.3 Product Benchmarking
      • 10.4.7.4 Strategic Initiatives
    • 10.4.8 Merck & Co., Inc.
      • 10.4.8.1 Company Overview
      • 10.4.8.2 Financial Performance
      • 10.4.8.3 Product Benchmarking
      • 10.4.8.4 Strategic Initiatives
    • 10.4.9 Astrazeneca
      • 10.4.9.1 Company Overview
      • 10.4.9.2 Financial Performance
      • 10.4.9.3 Product Benchmarking
      • 10.4.9.4 Strategic Initiatives
    • 10.4.10 Emergent
      • 10.4.10.1 Company Overview
      • 10.4.10.2 Financial Performance
      • 10.4.10.3 Product Benchmarking
      • 10.4.10.4 Strategic Initiatives
    • 10.4.11 Novavax
      • 10.4.11.1 Company Overview
      • 10.4.11.2 Financial Performance
      • 10.4.11.3 Product Benchmarking
      • 10.4.11.4 Strategic Initiatives
    • 10.4.12 Inovio Pharmaceuticals
      • 10.4.12.1 Company Overview
      • 10.4.12.2 Financial Performance
      • 10.4.12.3 Product Benchmarking
      • 10.4.12.4 Strategic Initiatives
    • 10.4.13 Moderna Inc.
      • 10.4.13.1 Company Overview
      • 10.4.13.2 Financial Performance
      • 10.4.13.3 Product Benchmarking
      • 10.4.13.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Respiratory Disease Vaccine Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 6 Global Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 7 Global Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 8 North America Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 11 North America Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 12 North America Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 U.S. Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 15 U.S. Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 16 U.S. Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Canada Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 19 Canada Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 20 Canada Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 Europe Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 24 Europe Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 25 Europe Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 Germany Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 28 Germany Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 29 Germany Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 UK Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 UK Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 32 UK Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 33 UK Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 France Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 France Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 36 France Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 37 France Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Italy Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 40 Italy Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 41 Italy Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Spain Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 44 Spain Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 45 Spain Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Denmark Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 48 Denmark Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 49 Denmark Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Sweden Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 52 Sweden Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 53 Sweden Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Norway Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 56 Norway Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 57 Norway Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Japan Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 65 Japan Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 66 Japan Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 China Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 China Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 69 China Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 70 China Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71 India Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 India Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 73 India Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 74 India Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 South Korea Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 77 South Korea Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 78 South Korea Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Australia Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 81 Australia Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 82 Australia Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Thailand Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 85 Thailand Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 86 Thailand Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Latin America Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 90 Latin America Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 91 Latin America Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Brazil Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 94 Brazil Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 95 Brazil Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 96 Mexico Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 97 Mexico Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 98 Mexico Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 99 Mexico Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 100 Argentina Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 102 Argentina Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 103 Argentina Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 113 South Africa Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 114 South Africa Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 115 South Africa Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 116 South Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 117 UAE Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 119 UAE Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 120 UAE Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Respiratory Disease Vaccine Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Respiratory disease vaccine market: Type outlook and key takeaways
  • Fig. 15 Respiratory disease vaccine market: Type movement analysis & market share 2022 & 2030
  • Fig. 16 Viral vaccines market, 2018 - 2030 (USD Million)
  • Fig. 17 Bacterial vaccine market, 2018 - 2030 (USD Million)
  • Fig. 18 Combination vaccine market, 2018 - 2030 (USD Million)
  • Fig. 19 Respiratory disease vaccine market: Age group outlook and key takeaways
  • Fig. 20 Respiratory disease vaccine market: Age group movement analysis & market share 2022 & 2030
  • Fig. 21 Pediatric market, 2018 - 2030 (USD Million)
  • Fig. 22 Adult market, 2018 - 2030 (USD Million)
  • Fig. 23 Respiratory disease vaccine market: Infection outlook and key takeaways
  • Fig. 24 Respiratory disease vaccine market: Infection movement analysis & market share 2022 & 2030
  • Fig. 25 COVID-19 market, 2018 - 2030 (USD Million)
  • Fig. 26 Influenza market, 2018 - 2030 (USD Million)
  • Fig. 27 Respiratory syncytial virus (RSV) market, 2018 - 2030 (USD Million)
  • Fig. 28 Pneumonia market, 2018 - 2030 (USD Million)
  • Fig. 29 Others antifungal drugs market, 2018 - 2030 (USD Million)
  • Fig. 30 Respiratory disease vaccine market: Distribution channel outlook and key takeaways
  • Fig. 31 Respiratory disease vaccine market: Distribution channel movement analysis & market share 2022 & 2030
  • Fig. 32 Hospital & retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Government suppliers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Regional Marketplace: Key Takeaways
  • Fig. 36 Regional Outlook, 2022 & 2030
  • Fig. 37 Regional Market Dashboard
  • Fig. 38 Regional Market Place: Key Takeaways
  • Fig. 39 North America, SWOT Analysis
  • Fig. 40 Europe, SWOT Analysis
  • Fig. 41 Asia Pacific, SWOT Analysis
  • Fig. 42 Latin America, SWOT Analysis
  • Fig. 43 MEA, SWOT Analysis
  • Fig. 44 North America
  • Fig. 45 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Key Country Dynamics
  • Fig. 47 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Canada Key Country Dynamics
  • Fig. 49 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe
  • Fig. 51 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 52 UK Key Country Dynamics
  • Fig. 53 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Germany Key Country Dynamics
  • Fig. 55 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 56 France Key Country Dynamics
  • Fig. 57 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Italy Key Country Dynamics
  • Fig. 59 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Spain Key Country Dynamics
  • Fig. 61 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark Key Country Dynamics
  • Fig. 63 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden Key Country Dynamics
  • Fig. 65 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Norway Key Country Dynamics
  • Fig. 67 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific Key Country Dynamics
  • Fig. 69 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Japan Key Country Dynamics
  • Fig. 71 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 72 China Key Country Dynamics
  • Fig. 73 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 74 India
  • Fig. 75 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Australia Key Country Dynamics
  • Fig. 77 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand Key Country Dynamics
  • Fig. 79 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea Key Country Dynamics
  • Fig. 81 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America
  • Fig. 83 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Brazil Key Country Dynamics
  • Fig. 85 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Mexico Key Country Dynamics
  • Fig. 87 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Argentina Key Country Dynamics
  • Fig. 89 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 90 MEA
  • Fig. 91 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 92 South Africa Key Country Dynamics
  • Fig. 93 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Saudi Arabia Key Country Dynamics
  • Fig. 95 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 96 UAE Key Country Dynamics
  • Fig. 97 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Kuwait Key Country Dynamics
  • Fig. 99 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Strategy Mapping